{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:01:53Z","timestamp":1793307713810,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hainan Province Clinical Medical Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Remimazolam is a new short-duration anesthetic currently used for gastroscopy and can be mixed with propofol and potent opioids.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>The study aimed to investigate the synergistic interaction between remimazolam and propofol after sufentanil administration and to determine the appropriate dose ratios between remimazolam and propofol.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>This study used a randomized controlled design. Patients scheduled for gastrointestinal endoscopy were included and randomized into five groups. The randomized block design was applied at a randomization ratio of 1:1. Patients in each group received sufentanil (0.1\u00a0\u03bcg\/kg) and the calculated doses of remimazolam and propofol. Using the up and down method, the median effective dose (ED<jats:sub>50<\/jats:sub>) and the 95% confidence interval (CI) were determined based on whether the eyelash reflex disappeared in each treatment group. Isobolographic analysis was used to analyze the presence of drug interactions. The interaction coefficient and the dose ratio between remimazolam and propofol were calculated by algebraic analysis. Statistical analysis was performed using interval estimates and 95% CI for statistical attributes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Cross-sectional analysis of the isobologram showed a clinically significant synergistic effect between remimazolam and propofol. When 0.016, 0.032, and 0.047\u00a0mg\/kg of remimazolam were combined with 0.477, 0.221, and 0.131\u00a0mg\/kg of propofol, the interaction coefficients were 1.04, 1.21, and 1.06, respectively. The dose ratio of remimazolam to propofol was approximately 1:7.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Remimazolam and propofol have synergistic clinical effects. A strong synergistic effect was observed when the remimazolam and propofol dose ratio was 1:7 (mg\/kg).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical trial<\/jats:title>\n                <jats:p>The study protocol was registered at the Chinese Clinical Trial Registry (ChiCTR2100052425).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11096-023-01568-y","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T16:02:54Z","timestamp":1681401774000},"page":"857-863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Randomized controlled trial for anesthesia during gastroscopy: interactions between remimazolam and propofol in combination with sufentanil"],"prefix":"10.1007","volume":"45","clinical-trial-number":[{"clinical-trial-number":"chictr2100052425","registry":"10.18810\/chictr"}],"author":[{"given":"Song","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchung","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1213\/ANE.0b013e3181da91bb","volume":"110","author":"BJ Lichtenbelt","year":"2010","unstructured":"Lichtenbelt BJ, Olofsen E, Dahan A, et al. Propofol reduces the distribution and clearance of midazolam. Anesth Analg. 2010;110:1597\u2013606.","journal-title":"Anesth Analg"},{"key":"1568_CR2","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1213\/ane.0b013e31819e4058","volume":"108","author":"J Vuyk","year":"2009","unstructured":"Vuyk J, Lichtenbelt BJ, Olofsen E, et al. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics. Anesth Analg. 2009;108:1522\u201330.","journal-title":"Anesth Analg"},{"key":"1568_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.mpaic.2012.07.008","volume":"13","author":"R Croft","year":"2012","unstructured":"Croft R, Washington S. Induction of anaesthesia. Anaesth Intensive Care Med. 2012;13:401\u20136.","journal-title":"Anaesth Intensive Care Med"},{"key":"1568_CR4","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3389\/fphar.2019.01222","volume":"10","author":"RY Huang","year":"2019","unstructured":"Huang RY, Pei L, Liu Q, et al. Isobologram analysis: a comprehensive review of methodology and current research. Front Pharmacol. 2019;10:1222.","journal-title":"Front Pharmacol"},{"key":"1568_CR5","unstructured":"Breitinger H-G. Drug synergy\u2014mechanisms and methods of analysis. https:\/\/www.intechopen.com\/chapters\/28118. Accessed 23 Feb 2023."},{"key":"1568_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","volume":"155","author":"NJ Pastis","year":"2019","unstructured":"Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate dedation during bronchoscopy. Chest. 2019;155:137\u201346.","journal-title":"Chest"},{"key":"1568_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/phar.1806","volume":"36","author":"AM Wesolowski","year":"2016","unstructured":"Wesolowski AM, Zaccagnino MP, Malapero RJ, et al. Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy. 2016;36:1021\u20137.","journal-title":"Pharmacotherapy"},{"key":"1568_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4103\/1119-3077.181366","volume":"19","author":"Y Xiong","year":"2016","unstructured":"Xiong Y, Xu Q, Wang Y, et al. Day surgery is effective and safe for patients with great saphenous vein varices who meet American Society of Anesthesiologists I-II grading. Niger J Clin Pract. 2016;19:455\u20139.","journal-title":"Niger J Clin Pract"},{"key":"1568_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1745-6215-13-90","volume":"13","author":"MJ Parker","year":"2012","unstructured":"Parker MJ, Manan A, Duffett M. Rapid, easy, and cheap randomization: prospective evaluation in a study cohort. Trials. 2012;13:90.","journal-title":"Trials"},{"key":"1568_CR10","doi-asserted-by":"publisher","first-page":"109899","DOI":"10.1016\/j.jclinane.2020.109899","volume":"66","author":"J Zhou","year":"2020","unstructured":"Zhou J, Leonowens C, Ivaturi VD, et al. Population pharmacokinetic\/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. J Clin Anesth. 2020;66:109899.","journal-title":"J Clin Anesth"},{"key":"1568_CR11","first-page":"1886","volume":"94","author":"Y Xu","year":"2014","unstructured":"Xu Y, Song X, Zhang G. ED50 of dexmedetomidine nasal drip in induction of hypnosis in children during computed tomography. Zhonghua Yi Xue Za Zhi. 2014;94:1886\u20138.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"1568_CR12","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1213\/01.ane.0000244534.24216.3a","volume":"103","author":"M Naguib","year":"2006","unstructured":"Naguib M, Samarkandi AH, Moniem MA, et al. The effects of melatonin premedication on propofol and thiopental induction dose-response curves: a prospective, randomized, double-blind study. Anesth Analg. 2006;103:1448\u201352.","journal-title":"Anesth Analg"},{"key":"1568_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/01.anes.0000267514.42592.2a","volume":"107","author":"NL Pace","year":"2007","unstructured":"Pace NL, Stylianou MP. Advances in and limitations of up-and-down methodology: a pr\u00e9cis of clinical use, study design, and dose estimation in anesthesia research. Anesthesiology. 2007;107:144\u201352.","journal-title":"Anesthesiology"},{"key":"1568_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/01621459.1965.10480843","volume":"60","author":"WJ Dixon","year":"1965","unstructured":"Dixon WJ. The up-and-down method for small samples. J Am Stat Assoc. 1965;60:967\u201378.","journal-title":"J Am Stat Assoc"},{"key":"1568_CR15","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1177\/009127009903901102","volume":"39","author":"R Yuan","year":"1999","unstructured":"Yuan R, Flockhart DA, Balian JD. Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam. J Clin Pharmacol. 1999;39:1109\u201325.","journal-title":"J Clin Pharmacol"},{"key":"1568_CR16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2147\/DDDT.S186759","volume":"13","author":"N Freyer","year":"2019","unstructured":"Freyer N, Kn\u00f6spel F, Damm G, et al. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Dev Ther. 2019;13:1033\u201347.","journal-title":"Drug Des Dev Ther"},{"key":"1568_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/00000542-200101000-00021","volume":"94","author":"MH Court","year":"2001","unstructured":"Court MH, Duan SX, Hesse LM, et al. Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. Anesthesiology. 2001;94:110\u20139.","journal-title":"Anesthesiology"},{"key":"1568_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40265-020-01299-8","volume":"80","author":"SJ Keam","year":"2020","unstructured":"Keam SJ. Remimazolam: first approval. Drugs. 2020;80:625\u201333.","journal-title":"Drugs"},{"key":"1568_CR19","doi-asserted-by":"publisher","first-page":"690875","DOI":"10.3389\/fphar.2021.690875","volume":"12","author":"GJ Kilpatrick","year":"2021","unstructured":"Kilpatrick GJ. Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent. Front Pharmacol. 2021;12:690875.","journal-title":"Front Pharmacol"},{"key":"1568_CR20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s00540-011-1176-6","volume":"25","author":"J Ohmori","year":"2011","unstructured":"Ohmori J, Maeda S, Higuchi H, et al. Propofol increases the rate of albumin-unbound free midazolam in serum albumin solution. J Anesth. 2011;25:618\u201320.","journal-title":"J Anesth"},{"key":"1568_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1096\/fj.02-0611fje","volume":"17","author":"R Jurd","year":"2003","unstructured":"Jurd R, Arras M, Lambert S, et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. FASEB J. 2003;17:250\u20132.","journal-title":"FASEB J"},{"key":"1568_CR22","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1213\/ANE.0000000000002022","volume":"124","author":"T Bevans","year":"2017","unstructured":"Bevans T, Deering-Rice C, Stockmann C, et al. Inhaled remimazolam potentiates inhaled remifentanil in rodents. Anesth Analg. 2017;124:1484\u201390.","journal-title":"Anesth Analg"},{"key":"1568_CR23","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/cts.13023","volume":"14","author":"J Zhou","year":"2021","unstructured":"Zhou J, Curd L, Lohmer LRL, et al. A population pharmacodynamic Markov mixed-effects model for determining remimazolam-induced sedation when co-administered with fentanyl in procedural sedation. Clin Trans Sci. 2021;14:1554\u201365.","journal-title":"Clin Trans Sci"},{"key":"1568_CR24","doi-asserted-by":"publisher","first-page":"173639","DOI":"10.1016\/j.ejphar.2020.173639","volume":"890","author":"MS Kops","year":"2021","unstructured":"Kops MS, Pesic M, Petersen KU, et al. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys. Eur J Pharmacol. 2021;890:173639.","journal-title":"Eur J Pharmacol"},{"key":"1568_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40981-021-00428-w","volume":"7","author":"S Tachibana","year":"2021","unstructured":"Tachibana S, Hayamizu K, Yamakage M. Remimazolam use for awake craniotomy. JA Clin Rep. 2021;7:25.","journal-title":"JA Clin Rep"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01568-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-023-01568-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01568-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T18:06:26Z","timestamp":1690221986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-023-01568-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1007\/s11096-023-01568-y","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"19 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}